|
Variables
|
EC group (n = 72)
|
No EC group (n = 156)
|
χ2/t
|
P
|
|---|
|
Age (y)
|
54.33 ± 9.26
|
46.12 ± 9.39
|
8.124
|
0.021
|
|
BMI (kg/m2)
|
27.16 ± 4.54
|
23.11 ± 5.95
|
6.101
|
0.036
|
|
Diabetes
|
39 (54.17%)
|
44 (28.21%)
|
1.114
|
0.019
|
|
Hypertension
|
52 (72.22%)
|
68 (43.59%)
|
1.271
|
0.038
|
|
Hyperlipidemia
|
17 (23.61%)
|
30 (19.23%)
|
1.855
|
0.076
|
|
Preoperative CA125 (U/ml)
|
21.69 ± 5.14
|
19.88 ± 4.24
|
1.232
|
0.095
|
|
Number of deliveries
|
|
0
|
8 (11.11%)
|
20 (12.82%)
|
1.140
|
0.011
|
|
1
|
22 (30.56%)
|
48 (30.77%)
| | |
|
2
|
37 (51.39%)
|
77 (49.36%)
| | |
|
≥ 3
|
5 (6.94%)
|
11 (49.36%)
| | |
|
Menopause
|
31 (43.06%)
|
63 (40.38%)
|
3.114
|
0.065
|
|
Pathology of EH
|
|
Mild hyperplasia
|
8 (11.11%)
|
59 (37.82%)
|
1.892
|
0.008
|
|
Moderate hyperplasia
|
20 (27.78%)
|
85 (54.49%)
| | |
|
Severe hyperplasia
|
44 (61.11%)
|
12 (7.69%)
| | |
|
Endometrial thickness (mm)
|
10.27 ± 3.21
|
9.98 ± 2.02
|
1.774
|
0.102
|
- EC endometrial cancer, EH endometrial hyperplasia
